etoposide
accord healthcare limited - etoposide - concentrate for soln for inf - 20 mg/ml - etoposide
etoposide 20mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare limited - etoposide - concentrate for solution for infusion - 20mg/ml
etoposide 20 mg/ml concentrate for soln for inf
cipla (eu) limited - etoposide - concentrate for soln for inf - 20 mg/ml - podophyllotoxin derivatives - it is indicated in adults for the management of: resistant non-seminomatous testicular tumours in combination with other chemotherapeutic agents; small cell lung cancer, in combination with other chemotherapeutic agents; acute monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard induction therapy has failed (in combination with other chemotherapeutic agents).
etoposide 20mg/ml concentrate for solution for infusion (100mg/5ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
etoposide 20mg/ml concentrate for solutionn for infusion (5ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
etoposide 20mg/ml concentrate for solutionn for infusion (10ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
etoposide 20mg/ml concentrate for solutionn for infusion (25ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
etoposide 20mg/ml concentrate for solutionn for infusion (50ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
etoposide 100mg/5ml concentrate for solution for infusion vials
accord-uk ltd - etoposide - solution for infusion - 20mg/1ml
etoposide 20mg/ml concentrate for solution for infusion (200mg/10ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents